| 1114 |
Centers for Disease Control and Prevention |
Html |
en |
You Can Control Your Asthma | CDC Features |
Learn to control your asthma. |
| allergies | 0.41507 |
| influenza | 0.414982 |
| asthma medicine | 0.650883 |
| CDC | 0.415812 |
| vaccinations | 0.416289 |
| asthma management plan | 0.712828 |
| asthma site | 0.666175 |
| vaccines | 0.416394 |
| pollen | 0.415987 |
| advice | 0.415795 |
| wheezing | 0.430879 |
| coughing | 0.446017 |
| pneumonia | 0.415989 |
| Regular physical exams | 0.540557 |
| third-hand tobacco smoke | 0.534328 |
| things | 0.432295 |
| chest tightness | 0.495401 |
| lungs | 0.44249 |
| Successful asthma management | 0.741783 |
|
| hospital | 0.415575 |
| episodes | 0.435177 |
| common triggers | 0.474798 |
| asthma attacks | 0.73272 |
| warning signs | 0.48409 |
| cases | 0.415924 |
| dust mites | 0.47636 |
| important thing | 0.477412 |
| Americans | 0.415169 |
| household pets | 0.475063 |
| asthma | 0.912482 |
| lifelong chronic diseases | 0.566062 |
| flu | 0.431034 |
| healthcare provider | 0.610528 |
| person | 0.427978 |
| Respiratory infections | 0.475012 |
| asthma symptoms | 0.670886 |
| breathlessness | 0.416215 |
|
CLICK HERE |
| 4661 |
Centers for Disease Control and Prevention |
Html |
en |
Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System |
null |
| high school | 0.378023 |
| data | 0.291262 |
| health insurance | 0.344181 |
| Risk Factor Surveillance | 0.28749 |
| PSA testing | 0.819899 |
| Prostate cancer treatments | 0.282713 |
| high school education | 0.31159 |
| elevated PSA | 0.30268 |
| BRFSS data | 0.285882 |
| PSA screening test | 0.361756 |
| PSA testing rate | 0.406824 |
| urinary tract symptoms | 0.264849 |
| smoking status | 0.267285 |
| PSA tests | 0.375297 |
| life satisfaction | 0.314139 |
| Preventive Services Task | 0.288986 |
| health care access | 0.281609 |
| prostate cancer symptoms | 0.271131 |
| total PSA testing | 0.336158 |
| PSA screening rate | 0.376904 |
| USPSTF prostate cancer | 0.318087 |
| PSA test | 0.903214 |
| Behavioral Risk Factor | 0.285081 |
| prostate cancer testing | 0.291446 |
|
| study | 0.2947 |
| logistic regression analysis | 0.278643 |
| prostate cancer status | 0.304853 |
| routine checkup | 0.293222 |
| indolent prostate cancers | 0.269528 |
| new USPSTF screening | 0.289712 |
| PSA screening | 0.403785 |
| men | 0.535737 |
| marital status | 0.270734 |
| USPSTF screening recommendation | 0.266489 |
| lower urinary tract | 0.264981 |
| health care | 0.314539 |
| new USPSTF prostate | 0.311145 |
| USPSTF screening guidelines | 0.349343 |
| multiple logistic regression | 0.334404 |
| emotional support | 0.451433 |
| prostate cancer guidelines | 0.272338 |
| Services Task Force | 0.291447 |
| veteran status | 0.265828 |
| prostate cancer screening | 0.325567 |
| prostate cancer | 0.805119 |
| psychosocial factors | 0.339763 |
| high school diploma | 0.370261 |
| coronary heart disease | 0.280406 |
|
CLICK HERE |
| 4979 |
Centers for Disease Control and Prevention |
Html |
en |
An organizing framework for translation in public health: the Knowledge to Action Framework |
null |
| critical translation processes | 0.500157 |
| routine public health | 0.478239 |
| limited public health | 0.485368 |
| public health researchers | 0.47595 |
| public health practitioners | 0.482599 |
| research | 0.536755 |
| translation framework | 0.476271 |
| Health Promotion | 0.491967 |
| Disease Control | 0.497235 |
| entire translation process | 0.481186 |
| widespread public health | 0.478263 |
| public’s health | 0.498984 |
| National Center | 0.480061 |
| organizational capacity | 0.51388 |
| World Health Organization | 0.472431 |
| Teresa J. Brady | 0.491403 |
| NCCDPHP K2A Framework | 0.529592 |
| public health practice | 0.519872 |
| NCCDPHP Work Group | 0.495022 |
| public health impact | 0.517782 |
| translation processes | 0.617815 |
| successful translation processes | 0.490411 |
| effective translation | 0.478149 |
| financial resources | 0.523472 |
| term translation | 0.482042 |
|
| interrelated elements | 0.478999 |
| intentional translation efforts | 0.474272 |
| K2A Framework | 0.699861 |
| successful translation | 0.498764 |
| scientific knowledge | 0.531875 |
| technical assistance | 0.545762 |
| public health outcomes | 0.476568 |
| public health | 0.953393 |
| Katherine M. Wilson | 0.490137 |
| chronic diseases | 0.473252 |
| public health need | 0.478038 |
| entire public health | 0.47212 |
| structures | 0.477035 |
| research phase | 0.479395 |
| public health actions | 0.479103 |
| Work Group | 0.503973 |
| Chronic Disease Prevention | 0.540884 |
| evidence-based programs | 0.583633 |
| translation | 0.756229 |
| evidence-based interventions | 0.517822 |
| federal public health | 0.472371 |
| translation efforts | 0.489581 |
| translation phase | 0.520019 |
| public health agency | 0.490234 |
|
CLICK HERE |
| 7974 |
Centers for Disease Control and Prevention |
Html |
en |
Critical Congenital Heart Defects in the United States - NCBDDD |
null |
| CCHD main screening | 0.434218 |
| specific CCHDs | 0.343097 |
| National Birth Defects | 0.514843 |
| Pregnancy termination rates | 0.359435 |
| Disease Control | 0.340689 |
| children | 0.357598 |
| care facilities | 0.358838 |
| Heart Defects Targeted | 0.594526 |
| training health care | 0.361515 |
| CCHD screening | 0.467624 |
| tricuspid valve atresia | 0.36484 |
| pulmonary venous return | 0.362592 |
| normal screening result | 0.416491 |
| Defects Monitoring Programs | 0.536393 |
| different states | 0.339989 |
| live births | 0.362003 |
| Congenital Heart Defects | 0.602865 |
| simple bedside test | 0.366608 |
| specific CCHD | 0.341714 |
| main screening targets | 0.475356 |
| Molecular Teratology. | 0.357143 |
| newborn screening | 0.686175 |
| defects surveillance programs | 0.665835 |
| Recommended Uniform Screening | 0.472029 |
| Birth Defects Monitoring | 0.546697 |
|
| Essential Public Health | 0.425369 |
| U.S. Recommended Uniform | 0.364777 |
| newborn screening programs | 0.438344 |
| United States | 0.405326 |
| babies | 0.351546 |
| Birth Defects Research | 0.571803 |
| way programs | 0.344973 |
| birth defects surveillance | 0.670514 |
| Public Health Roles | 0.425796 |
| health services | 0.352613 |
| critical congenital heart | 0.789819 |
| congenital heart disease | 0.487833 |
| CCHDs | 0.428054 |
| Pulse Oximetry Screening | 0.563436 |
| Uniform Screening Panel | 0.471899 |
| 50 states | 0.34081 |
| heart syndrome | 0.342317 |
| Population-based Birth Defects | 0.612595 |
| birth defects | 0.961121 |
| certain medical conditions | 0.369692 |
| birth defects data | 0.659331 |
| new U.S. data | 0.379031 |
| CCHD newborn screening | 0.442181 |
| information | 0.357295 |
|
CLICK HERE |
| 9661 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH A-Z Index - G |
null |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 10067 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Immune Diseases : Goals |
The mission of the NIOSH research program for Immune, Dermal & Infectious Diseases is to eliminate occupational injuries, illnesses, and fatalities among workers in these industries through a focused program of research and prevention. Primary efforts are focused on hazard identification since when potential hazards are recognized, work-related dermal and immune diseases can often be prevented or their effects minimized. |
| occupational asthma | 0.673934 |
| current governmental approaches | 0.672232 |
| effective prevention strategies | 0.654356 |
| significant health risks | 0.690684 |
| normal immune function | 0.90514 |
| risk assessment strategies | 0.663448 |
| altered immune function | 0.744156 |
| immune responses | 0.695158 |
| indoor air chemicals | 0.669711 |
| sector programs | 0.791804 |
| NIOSH sector program | 0.78076 |
| occupational allergen exposures | 0.776647 |
| NIOSH Sector Programs | 0.788906 |
| potential indoor air | 0.65678 |
| infectious cough-generated aerosols | 0.652851 |
| specific allergic mediators | 0.670244 |
| allergic skin sensitization | 0.688585 |
| allergic rhinitis | 0.698576 |
| Intermediate Goal | 0.921013 |
| safer exposure levels | 0.66935 |
| health effects | 0.902367 |
| immune diseases goal | 0.751273 |
| Program Assessment Rating | 0.681504 |
| mold-contaminated workplaces | 0.674902 |
| Provide scientific data | 0.746807 |
|
| immune parameters | 0.669812 |
| NIOSH Immune | 0.738999 |
| adverse health outcomes | 0.683604 |
| cross-sector programs | 0.680975 |
| adverse health effects | 0.677532 |
| Cross Sector programs | 0.705106 |
| NORA Sector Council | 0.680752 |
| program goals | 0.660999 |
| immune function | 0.913089 |
| NIOSH Program Portfolio | 0.761671 |
| associated pathophysiological disorders | 0.661336 |
| certain occupational chemicals | 0.716341 |
| Fishing Program goal | 0.702708 |
| fungal exposure | 0.660668 |
| immune abnormalities | 0.7581 |
| occupational exposures | 0.751568 |
| occupational allergens | 0.725208 |
| clinical disease | 0.670005 |
| indoor air | 0.763389 |
| exposure-related health effects | 0.676322 |
| significant health effects | 0.671699 |
| certain work environments | 0.672218 |
| various sectors | 0.662471 |
| health risks | 0.737673 |
|
CLICK HERE |
| 10463 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: July 1, 2013'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| injury data collection | 0.772013 |
| CDC | 0.895655 |
| Involving Inhalation Anthrax | 0.770935 |
| Emergency Preparedness | 0.788271 |
| Respiratory Syndrome Coronavirus | 0.782788 |
| FDA Safety Information | 0.767061 |
| emergency risk communication | 0.925078 |
| state level response | 0.796992 |
| effective response | 0.706826 |
| Previous COCA Conference | 0.792537 |
| – (CDC) | 0.788089 |
| new avian influenza | 0.774919 |
| CDC Science Clips | 0.880885 |
| CDC Influenza Division | 0.86601 |
| new H7N9 virus | 0.7674 |
| important safety information | 0.763668 |
| alternative treatment sites | 0.771022 |
| racial/ethnic minority groups | 0.760038 |
| health care providers | 0.869685 |
| Weekly Flu View | 0.765101 |
| Free CE credit/contact | 0.757319 |
| human medical products | 0.752516 |
| disaster preparedness | 0.716425 |
| health messaging | 0.718014 |
|
| exciting new content | 0.762796 |
| play important roles | 0.775394 |
| Current Travel Warnings | 0.751791 |
| seasonal flu | 0.743678 |
| Event Reporting Program | 0.753214 |
| State Health Departments | 0.808596 |
| East Respiratory Syndrome | 0.878547 |
| pre-hospital transport decision | 0.765607 |
| respiratory illness | 0.764727 |
| COCA Email Update | 0.818941 |
| public health community | 0.806541 |
| Public Health Practice | 0.803791 |
| public health | 0.837018 |
| Risk Communication Course | 0.764974 |
| Specific Hazards preparedness | 0.783678 |
| Middle East Respiratory | 0.878583 |
| public opinion polls | 0.772598 |
| in-person training centers | 0.758331 |
| Eastern Time | 0.788664 |
| FoodSafety.gov Reports FDA | 0.765252 |
| weekly influenza surveillance | 0.761273 |
| severe respiratory illness | 0.760727 |
| USDA Food Recalls | 0.750749 |
| Response Training Resources | 0.782253 |
|
CLICK HERE |
| 11886 |
Centers for Disease Control and Prevention |
Html |
en |
Pertussis | Whooping Cough | Prevention | Infants & Children | CDC |
null |
| cold symptoms | 0.604524 |
| DTaP vaccines | 0.575845 |
| DTaP shots | 0.574879 |
| doses | 0.242266 |
| CDC | 0.21973 |
| Español | 0.292722 |
| Tdap shot | 0.584743 |
| best way | 0.663849 |
| babies | 0.592162 |
| pertussis | 0.987679 |
| maximum protection | 0.648495 |
|
| whooping cough | 0.838349 |
| tetanus | 0.256714 |
| dose | 0.230007 |
| Pregnant women | 0.625591 |
| children | 0.62353 |
| Bebés y niños | 0.701859 |
| olds | 0.224315 |
| pertussis vaccine | 0.978059 |
| Prevención | 0.212079 |
| combination vaccine | 0.714881 |
| Parents-to-be | 0.269073 |
|
CLICK HERE |
| 12249 |
Centers for Disease Control and Prevention |
Video |
en |
Binge Drinking |
The video explores the health risks of BINGE DRINKING ? including unintended pregnancy, sexually transmitted diseases, injury, car crashes, violence and HIV/AIDS ? and discusses effective community prevention strategies such as increasing alcohol excise taxes. The video also features experts who debunk common myths including the belief that BINGE DRINKING is only a problem among youth. For more information on this topic visit http://www.cdc.gov/VitalSigns/BingeDrinking
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at http://www.cdc.gov/CDCTV/BingeDrinking |
|
|
CLICK HERE |
| 13364 |
Centers for Disease Control and Prevention |
Html |
en |
Student Indoor Tanning | CDC Features |
Learn about two PRCs’ discovery of indoor tanning use among college students. |
| skin cancer | 0.650173 |
| especially indoor tanning | 0.533057 |
| college campuses | 0.388157 |
| American Academy | 0.433008 |
| ID/debit card | 0.391218 |
| research letter | 0.381095 |
| Indoor tanning exposes | 0.581668 |
| Human Services | 0.415646 |
| indoor tanning exposure | 0.538292 |
| San Diego County | 0.375873 |
| Denver researchers | 0.424116 |
| Prevent Skin Cancer. | 0.390952 |
| college ID/debit card | 0.388299 |
| intentional tanning | 0.468887 |
| university debit cards | 0.411373 |
| residential 4-year universities | 0.419887 |
| Prevent Skin Cancer | 0.443859 |
| California census tracts | 0.372752 |
| indoor tanning merchants | 0.54499 |
| student health services | 0.399891 |
| potential health risks | 0.387799 |
| medicine residency program | 0.376666 |
| Skin Cancer Executive | 0.399395 |
| young adult patients | 0.380525 |
|
| Virginia Polytechnic Institute | 0.381767 |
| young adults | 0.385495 |
| Fifty-three universities | 0.37772 |
| debit cards | 0.545731 |
| unlimited indoor tanning | 0.557588 |
| undergraduate student body | 0.389946 |
| Prevention Research Center | 0.398449 |
| student indoor tanning | 0.539166 |
| college students | 0.399925 |
| Research Centers Program | 0.387212 |
| indoor tanning increases | 0.560412 |
| higher risk | 0.390603 |
| indoor tanning salons | 0.620687 |
| Medical School—Worcester PRC | 0.390579 |
| Prevention Research Centers | 0.471525 |
| indoor tanning | 0.911476 |
| Southern New Hampshire | 0.383539 |
| Western Kentucky University | 0.403528 |
| student ID/debit card | 0.388617 |
| Surgeon General | 0.448885 |
| Melanoma results | 0.367357 |
| off-campus housing | 0.393004 |
| frequent indoor tanning | 0.557885 |
| et al | 0.425757 |
|
CLICK HERE |